Selective adenylate cyclase increase in the limbic area of long-term imipramine-treated rats.
Long-term administration of imipramine to rats produced an increase in the Vmax of forskolin- or guanylylimidodiphosphate (Gpp(NH))p-activated adenylate cyclase only in the limbic area. This effect was prevented by the daily administration of alpha-methyl-p-tyrosine (alpha-MPT), given together with imipramine, at a dose (50 mg/kg) which had no effect on adenylate cyclase activity per se. The time course of the effects of chronic imipramine on dopaminergic transmission in the limbic area showed that the decrease in both D-1 receptor number and adenylate cyclase stimulation by dopamine (DA) reached significance on day 8 of treatment and were maximal on day 15. The Vmax of the enzyme started to increase on day 15 and was further increased on day 21. Possible mechanisms underlying these effects are discussed.
De Montis
G M
GM
Institute of Pharmacology and Biochemical Pathology, University of Cagliari, Italy.
Devoto
P
P
Gessa
G L
GL
Porcella
A
A
Serra
G
G
Tagliamonte
A
A
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology*; D066298:In Vitro Techniques; D008032:Limbic System / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D019805:alpha-Methyltyrosine
D001552:Benzazepines; D008781:Methyltyrosines; D006165:Guanylyl Imidodiphosphate; D019805:alpha-Methyltyrosine; D000262:Adenylyl Cyclases; D007099:Imipramine